Humana Q4 Revenue Rises 11.3% with 7.6% Medicare PDP Growth
Humana’s Q4 2025 revenue rose 11.3% as specialty membership grew 4% and Medicare PDP volumes increased 7.6%, while it held $4.2B cash and no short-term debt against a $21.1B market cap. It repurchased $151M in shares and paid $430M in dividends while benefit ratio widened to 93%, pressuring profitability.
1. Q4 2025 Revenue and Membership
Humana’s Q4 2025 revenues increased 11.3% year-over-year, driven by a 4% rise in specialty membership and 7.6% growth in Medicare stand-alone PDP enrollment, underscoring demand for its senior-focused plans.
2. Capital Position and Shareholder Returns
As of December 31, 2025, Humana held $4.2 billion in cash and equivalents with no short-term debt. The company repurchased $151 million of shares and paid $430 million in dividends in 2025, though its 2% dividend yield trails larger peers.
3. Margin Pressure and Cost Challenges
Operating expenses jumped 12% in Q4 due to higher benefits and administrative costs, pushing the benefit ratio to 93%, up 150 basis points year-over-year. Elevated medical cost ratios heighten Humana’s exposure to government reimbursement shifts and rating changes.